| Several US and Canadian companies have stopped clinical trials in India following an amendment to the rules, which they say, could lead to "unreasonable claims" by subject-patients. | |||
| | |||
| | |||
|
| Several US and Canadian companies have stopped clinical trials in India following an amendment to the rules, which they say, could lead to "unreasonable claims" by subject-patients. | |||
| | |||
| | |||
|
No comments:
Post a Comment